Expansion opportunities Recent product launches across multiple analyte lines and instrument compatibilities (Ortho Vitros Linearity, LQ Osmolality, Vitamin D, Ammonia/Ethanol, Special Diabetes, HbA1c) indicate active growth and diversification. Sales strategy should target labs using these platforms and promote AUDIT’s broad calibration verification and daily quality control solutions to capture incremental spend per instrument.

Strategic partnerships Partnership with Aalto Scientific enhances cost savings and breadth of solution coverage. Leverage this alignment to position AUDIT as a value-driven supplier that can streamline procurement, reduce total cost of ownership, and consolidate vendors for clinical labs seeking efficiency and reliability.

Quality & usability Auditable quality controls and easy-to-use data management tools are core differentiators. Highlight the integrated data management capabilities and personalized service to labs aiming to improve compliance, traceability, and turnaround time, particularly in high-volume settings.

SMB growth focus Company size (11-50 employees) and Georgia-based operations suggest approachable, responsive service for mid-market labs. Target regional hospitals, independent labs, and small-to-mid-size reference labs that benefit from tailored support and faster deployment cycles.

Tech-enabled selling Tech stack includes Zoho PageSense, MySQL, and cloud-enabled tools, enabling data-driven outreach and streamlined ordering. Use targeted digital campaigns, site personalization, and easy integration messaging to demonstrate quick ROI and measurable quality improvements to prospective buyers.